Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. CSL (ASX:CSL) has outlined a restructuring plan that ...

Carlisle Companies Incorporated (NYSE:CSL) is included among the 15 Best Safe Dividend Stocks for 2026. On March 9, JPMorgan raised its price recommendation on Carlisle Companies Incorporated ...

CSL Ltd. plunged the most on record after the Australian biotechnology company cut its full-year outlook and flagged about $5 billion in additional impairments, warning a turnaround will take longer ...

One day after CSL suddenly replaced its CEO, the company provided dismal financial figures that helped explain why. In its half-year report, CSL said its net profit plummeted (PDF) from $2 billion in ...

CSL has gotten the Memo about the value of recombinant polyclonal immunoglobulin (IgG) antibodies. The company is signing on to a collaboration and option agreement with Memo Therapeutics that could ...

Carlisle Companies Inc (CSL) reports a resilient quarter with margin expansion and strategic product launches amid revenue decline.

Is there more pain in store for CSL shareholders? The post Where to from here for CSL shares according to Macquarie appeared ...

Earnings call CSL reported H1 FY25 revenue of AUD 8.5B (+5% YoY, constant currency) and NPATA of AUD 2.1B (+5%), reaffirming FY25 NPATA guidance of AUD 3.2–3.3B (+10–13%). Behring led with 10% revenue ...

CSL granted Eli Lilly certain rights for clazakizumab CSl to receive upfront payment of $100 million CSL shares up 2.1% CSL will retain exclusive rights to develop and commercialise clazakizumab for ...